Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2020-01-30 | 2020-04-02 | 104899 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-01-30 | 2020-06-11 | 104908 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-02-07 | 2020-04-09 | 105561 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105570 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2020-02-07 | 2020-05-08 | 105576 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2020-02-07 | 2021-04-01 | 105590 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-13 | 2020-03-12 | 106008 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-02-13 | 2020-03-19 | 106015 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-02-13 | 2020-04-09 | 106021 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106913 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2020-02-21 | 2020-04-02 | 106916 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106919 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-19 | 106928 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-21 | 2020-05-01 | 106931 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Actual shortage | 2020-02-21 | 2020-03-26 | 106945 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
| TEVA-BROMAZEPAM | 6MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107952 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |